These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 22156346

  • 1. Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1.
    Morris JE, Zobell S, Yin XT, Zakeri H, Summers BC, Leib DA, Stuart PM.
    J Immunol; 2012 Jan 15; 188(2):793-9. PubMed ID: 22156346
    [Abstract] [Full Text] [Related]

  • 2. Impaired Fas-Fas Ligand Interactions Result in Greater Recurrent Herpetic Stromal Keratitis in Mice.
    Yin XT, Keadle TL, Hard J, Herndon J, Potter CA, Del Rosso CR, Ferguson TA, Stuart PM.
    J Immunol Res; 2015 Jan 15; 2015():435140. PubMed ID: 26504854
    [Abstract] [Full Text] [Related]

  • 3. Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis.
    Nguyen QD, Uy HS, Merchant A, Medina CA, Baltatzis S, Zhao T, Zhao ZS, Cantor H, Foster CS.
    Invest Ophthalmol Vis Sci; 2001 Oct 15; 42(11):2505-9. PubMed ID: 11581190
    [Abstract] [Full Text] [Related]

  • 4. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
    Wahlsten JL, Gitchell HL, Chan CC, Wiggert B, Caspi RR.
    J Immunol; 2000 Nov 15; 165(10):5480-6. PubMed ID: 11067900
    [Abstract] [Full Text] [Related]

  • 5. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.
    Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT.
    J Immunol; 2004 Jan 15; 172(2):1237-45. PubMed ID: 14707102
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in Mice.
    Rogge M, Yin XT, Godfrey L, Lakireddy P, Potter CA, Del Rosso CR, Stuart PM.
    Invest Ophthalmol Vis Sci; 2015 Oct 15; 56(11):6377-86. PubMed ID: 26444718
    [Abstract] [Full Text] [Related]

  • 7. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
    Omokaro SO, Desierto MJ, Eckhaus MA, Ellison FM, Chen J, Young NS.
    J Immunol; 2009 Mar 15; 182(6):3414-22. PubMed ID: 19265119
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.
    Xia L, Zhang S, Cao Z, Hu Y, Yang H, Wang D.
    Microbes Infect; 2013 Feb 15; 15(2):126-39. PubMed ID: 23159245
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
    Kovacs SK, Tiwari V, Prandovszky E, Dosa S, Bacsa S, Valyi-Nagy K, Shukla D, Valyi-Nagy T.
    Curr Eye Res; 2009 Oct 15; 34(10):896-904. PubMed ID: 19895317
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of Sex Differences in Ocular Herpes Simplex Virus 1 Infection and Herpes Stromal Keratitis Pathogenesis of Wild-Type and Herpesvirus Entry Mediator Knockout Mice.
    Riccio RE, Park SJ, Longnecker R, Kopp SJ.
    mSphere; 2019 Mar 27; 4(2):. PubMed ID: 30918059
    [Abstract] [Full Text] [Related]

  • 18. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
    Fecho K, Cohen PL.
    J Leukoc Biol; 1998 Sep 27; 64(3):373-83. PubMed ID: 9738665
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.